Institution statistics

NANOPHARMA AS - Czech Republic 

Ranking results:

Past rankings:
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2010-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2018 0 9.584.411 535.875 3
2013 0 5.996.455 899.473 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Constancy:

Total number of partners:40

Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 40

Frequent / Rare Partner Ratio: 0

Diversity:

Subjects:
Subject:No:
LIFE SCIENCES1
Diversity index:1
Categories:
Category:No:
BIOLOGICAL SCIENCES1

Project overview:

Start dateProjectacronymrolefundingpartners
2018-02-01Innovative packaging solutions for storage and conservation of 20th century cultural heritage of artefacts based on cellulose derivate NEMOSINEparticipant7.293.91117
2018-01-01Novel 1D photonic metal oxide nanostructures for early stage cancer detection CanBioSeparticipant1.282.50011
2018-01-01Nanostructural surface development for dental implant manufacturing NanoSurfparticipant1.008.0009
2013-10-01Development of Stem Cell Based Therapy for Thymic Regeneration THYMISTEMparticipant5.996.4557
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum